News Announcement

Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Investor Presentation

Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that a conference call on acquisition of Sandozs dermatology and oral solids businesses is scheduled on 6th September 2018 at 5:30 PM
Please find attached the dial-in details of the call.
In this connection, we enclose herewith the presentation that would be used in the aforesaid conference call.
The presentation is also being uploaded on the website of the Company - http://www.aurobindo.com/investor-relations/investors/investor-presentation

वैल्यू रिसर्च से पूछें aks value research information

कोई सवाल छोटा नहीं होता. पर्सनल फ़ाइनांस, म्यूचुअल फ़ंड्स, या फिर स्टॉक्स पर बेझिझक अपने सवाल पूछिए, और हम आसान भाषा में आपको जवाब देंगे.